AKT1 and esophageal squamous cell carcinoma: Our findings support the notion that radiotherapy‐activated CAFs contribute to ESCC metastasis post‐radiotherapy and provide a rationale for targeting irradiated CAF‐driven miR‐193a‐3p‐Akt signalling to improve radiotherapy outcomes of ESCC patients.